Investigation on the isoform selectivity of histone deacetylase inhibitors using chemical feature based pharmacophore and docking approaches

被引:16
作者
Zhu, Yong [1 ]
Li, Hui-Fang [1 ]
Lu, Shuai [1 ]
Zheng, Yi-Xuan [1 ]
Wu, Zeng [1 ]
Tang, Wei-Fang [1 ]
Zhou, Xiang [1 ]
Lu, Tao [1 ]
机构
[1] China Pharmaceut Univ, Dept Organ Chem, Nanjing 210009, Peoples R China
关键词
HDAC1; inhibitors; Pharmacophore; Molecular docking; Selectivity; AMIDE ANALOGS; DERIVATIVES; DESIGN; CANCER; POTENT; HDAC; ACID; TRICHOSTATIN; ACETYLATION; SHI-1/2;
D O I
10.1016/j.ejmech.2010.01.010
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A three dimensional (3D) chemical feature based pharmacophore model was developed for selective histone deacetylase 1 (HDAC1) inhibitors, which provides an efficient way to discuss the isoform selectivity of HDAC inhibitors. In contrast to the classical pan-HDAC pharmacophore, two hydrophobic features (HY and HYAr2) were found in the chemical feature based pharmacophore model, which might be responsible for the selectivity of HDAC1 inhibitions. Molecular docking also highlighted the two hydrophobic features, which are located in the internal cavity adjacent to the active site. The results contribute to our understanding of the molecular mechanism underlying the selectivity of HDAC1 inhibitors and suggest a possible target region to design novel selective HDAC1 inhibitors. (C) 2010 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:1777 / 1791
页数:15
相关论文
共 34 条
[1]   Applicability of CATALYST in ecotoxicology, a new promising tool for 3D-QSAR: Study of chlorophenols [J].
Briens, F ;
Bureau, R ;
Rault, S .
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY, 1999, 43 (03) :241-251
[2]   Identification of ligand features essential for HDACs inhibitors by pharmacophore modeling [J].
Chen, Ya-dong ;
Jiang, Yong-Jun ;
Zhou, Jian-Wei ;
Yu, Qing-Sen ;
You, Qi-Dong .
JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2008, 26 (07) :1160-1168
[3]   3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment [J].
Chen, Yadong ;
Li, Huifang ;
Tang, Wanquan ;
Zhu, Chengchao ;
Jiang, Yongjun ;
Zou, Jianwei ;
Yu, Qingsen ;
You, Qidong .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (07) :2868-2876
[4]   Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors [J].
Finnin M.S. ;
Donigian J.R. ;
Cohen A. ;
Richon V.M. ;
Rifkind R.A. ;
Marks P.A. ;
Breslow R. ;
Pavletich N.P. .
Nature, 1999, 401 (6749) :188-193
[5]   Trifluoromethyl ketones as inhibitors of histone deacetylase [J].
Frey, RR ;
Wada, CK ;
Garland, RB ;
Curtin, ML ;
Michaelides, MR ;
Li, JL ;
Pease, LJ ;
Glaser, KB ;
Marcotte, PA ;
Bouska, JJ ;
Murphy, SS ;
Davidsen, SK .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (23) :3443-3447
[6]   Potent histone deacetylase inhibitors built from trichostatin A and cyclic tetrapeptide antibiotics including trapoxin [J].
Furumai, R ;
Komatsu, Y ;
Nishino, N ;
Khochbin, S ;
Yoshida, M ;
Horinouchi, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) :87-92
[7]   Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA [J].
Glaser, KB ;
Li, JL ;
Staver, MJ ;
Wei, RQ ;
Albert, DH ;
Davidsen, SK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 310 (02) :529-536
[8]   Vorinostat [J].
Grant, Steven ;
Easley, Chris ;
Kirkpatrick, Peter .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (01) :21-22
[9]   Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis [J].
Gregoretti, IV ;
Lee, YM ;
Goodson, HV .
JOURNAL OF MOLECULAR BIOLOGY, 2004, 338 (01) :17-31
[10]   Deacetylase enzymes: biological functions and the use of small-molecule inhibitors [J].
Grozinger, CM ;
Schreiber, SL .
CHEMISTRY & BIOLOGY, 2002, 9 (01) :3-16